New Hair Loss Treatment Clinical Trials

Share |

Nanogen's scope for hair loss treatment widens as they become involved with large scale clinical trials.

(I-Newswire) February 23, 2010 - The thinning hair experts from the UK - Nanogen are planning to be involved in no less than 4 clinical trials in 3 countries, involving both the increasingly popular Scalproller device and other cutting edge therapeutic techniques.
Nanogen widens their scope for hair loss treatment, becoming involved with large scale clinical trials for the extremely promising Platelet Rich Plasma treatment. Platelet Rich Plasma therapy received much applause when early results found it could not only improve hair growth and survival of transplanted hair, but also re-grew hair in a patient with Alopecia Areata. Nanogen hopes to be able to reinforce these early findings with larger trials, and contribute to newer growth-factor hair loss treatments. Other trials with Nanogen’s hair growth maintenance range are planned but details are not yet available.
Aside from research with existing products, Nanogen is collaborating with the University of Bonn to produce an accurate genetic test for hair loss, and has an exclusive agreement with researchers in Bonn to use chromosome 20 as the basis for a test to predict hair loss, as well as accurately diagnose Androgenetic Alopecia patients.
The company also plans to further bolster their professional background with the formation of a dedicated Expert Panel of hair transplant surgeons, trichologists, dermatologists and even grooming experts to advise and contribute to current and future hair loss research.
Nanogen will continue their ambitious programme of research throughout the New Year and beyond. For more information on Nanogen’s products and hair loss research please visit www.nanogen.org.
---Ends---
Editor’s Notes:
Nanogen is a trademarked brand of Pangaea Laboratories Ltd. Founded in 1999 by pharmacologist Elliot Isaacs, Pangaea has always maintained high standards of scientific research, and all their products are developed with the aim of delivering cutting edge cosmetic technology to the public. This release was written by Toby Cobbledick, for any further information, please contact toby@pangaea.co.uk or +44 (0)20 8458 2500

Company Contact Information
Nanogen

Print Release

Share this News Release

Published in:

Medical

Tags:

Hair loss Thinning hair research clinical trials

Published on:

February 23, 2010

Content Disclaimer: If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service company and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter,make sure to check the official company website for accurate release dates as our site displays the date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.

Related Releases

Odessa’s Healthy Heart Center Celebrates Ten Years of Helping Heart Patients Live Active, Symptom-Free Lives with the Assistance of Non-Invasive EECP® Therapy
Healthy Heart’s medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center’s patients

Helping Men To Perform To Their Best Abilities
Michael S. Kaplan was presented with an award by the Nevada Family Practice Association as “Consultant of the Year” and Las Vegas Magazine as “Top Doctor”. See how he can help resolve your concerns.

Registration Open for 1st Cancer Cachexia Conference in Boston, MA on September 21-23, 2012
We are pleased to announce that registration is now open for the first Cancer Cachexia Conference entitled, “Cancer Cachexia: Molecular Mechanisms and Therapeutic Approaches” to be held in Boston, USA on September 21-23, 2012, co-hosted by The Oh

Boston Cosmetic Surgery Center Introduces ChestSculpt for Treatment of Gynecomastia
May 16, 2012 -- Marshfield, MA - (May 16, 2012)-- Edwin Ishoo, MD, a cosmetic surgeon in Marshfield and Brookline, Massachusetts area, is pleased to offer ChestSculpt, an innovative and advanced procedure for treatment of gynecomastia.

Great Wall Chinese Medicine Has Big Event of Diabetes
This is a phenomenal opportunity for the public to learn techniques for well-being and to learn the newest information on Diabetes Prevention from one of the top Diabetes Experts in the world, Dr. Wang who will only be in the United States for 10 day